Uptake of a 21-Gene Expression Assay in Breast Cancer Practice: Views of Academic and Community-Based Oncologists
Abstract
Share and Cite
O’Brien, M.A.; Dhesy-Thind, S.; Charles, C.; Mobilio, M.H.; Leighl, N.B.; Grunfeld, E. Uptake of a 21-Gene Expression Assay in Breast Cancer Practice: Views of Academic and Community-Based Oncologists. Curr. Oncol. 2017, 24, 138-145. https://doi.org/10.3747/co.24.3395
O’Brien MA, Dhesy-Thind S, Charles C, Mobilio MH, Leighl NB, Grunfeld E. Uptake of a 21-Gene Expression Assay in Breast Cancer Practice: Views of Academic and Community-Based Oncologists. Current Oncology. 2017; 24(2):138-145. https://doi.org/10.3747/co.24.3395
Chicago/Turabian StyleO’Brien, M.A., S. Dhesy-Thind, C. Charles, M. Hammond Mobilio, N.B. Leighl, and E. Grunfeld. 2017. "Uptake of a 21-Gene Expression Assay in Breast Cancer Practice: Views of Academic and Community-Based Oncologists" Current Oncology 24, no. 2: 138-145. https://doi.org/10.3747/co.24.3395